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Juan C. Celedon1*, Giovanni Passalacqua2 and Giorgio Walter Canonica2As co-Editors in Chief (and Professor Canonica as Presi-
dent of Interasma), it is our pleasure to welcome our col-
leagues to this first issue of the journal Asthma Research
and Practice (ARP) [1]. This will be an open-access online
journal, and thus easily accessible to a large audience. The
aims and scope of ARP will be to publish original research
articles and state of the art reviews focusing on risk fac-
tors, diagnosis and management of asthma at all ages.
Since asthma is a disease that comprises diverse endotypes
and is often accompanied by co-morbidities, we expect
and welcome manuscripts on topics such as “obese
asthma”, exercise-induced asthma, asthma-COPD overlap
syndrome, occupational asthma, and others [2, 3].
Although existing journals in fields as diverse as paediat-
rics, internal medicine, allergy and pulmonology include
articles on asthma, we believe that a journal entirely dedi-
cated to asthma is both valuable and necessary. Moreover,
we are committed to have a section devoted entirely to
pediatric asthma, one of the most common chronic dis-
eases of childhood in industrialized nations.
The title of this new journal include the word “prac-
tice” to emphasize our explicit intent to address practical
aspects of asthma diagnosis and management, which are
of greatest interest to the physicians and health care pro-
fessionals caring for millions of children and adults with
asthma worldwide. Thus, the Editors and the Editorial
Board of ARP are committed to link mechanistic and
practical knowledge of asthma in future years. We want
to emphasize the strict cooperation between the Journal
and Interasma [4]. This latter organization, founded in
1954 and currently chaired by Prof. G.W. Canonica, has
the main missions of bridging the gaps between academy
and clinical practice and of establishing an interdisciplin-
ary forum on asthma worldwide. Notably, this mission is
largely in agreement with that of ARP.* Correspondence: juan.celedon@chp.edu
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unless otherwise stated.All manuscripts submitted to ARP will undergo a thor-
ough peer-review process by physicians and scientists with
relevant expertise. The Editorial Board [5] of ARP is com-
mitted to ensure a fair but reasonably expeditious peer-
review process, followed by immediate online publication of
accepted manuscripts as free articles, which will be access-
ible in PubMed. The Editors and the Editorial Board further
commit and expect that ARP will rapidly get an Impact Fac-
tor that reflects the quality and value of this journal.
We would like to express our profound gratitude to our
dear colleague and friend, Professor Carlos Baena-Cagnani.
Carlos conceived and enthusiastically supported the
preparation and launching of this journal, which is and
will always be a tribute to his memory.
The first publications in ARP include two original re-
search articles and a comprehensive review. The first
article reports the findings of a Phase I clinical trial of
vitamin D supplementation in patients with cystic fibro-
sis and allergic bronchopulmonary aspergillosis (ABPA),
a condition that causes significant morbidity in patients
with asthma [6]. Although preliminary by design, this
Phase I trial demonstrates the efficacy of the tested dose
of vitamin D (4,000 IU/day) in both achieving vitamin D
sufficiency and reducing Th2 immune responses relevant
to ABPA and other allergic conditions such as asthma.
The second article reports the findings of an Italian
questionnaire-based survey about respiratory allergy, as
described by patients referred to pharmacists for their
symptoms [7]. This aspect is of special interest, since
pharmacists are usually the first-line referral. The Au-
thors found that 11 % of patients who accessed pharma-
cies had only lower respiratory symptoms, but that a
large fraction of the population had co-existing upper
and lower respiratory symptoms. Notably, about 50 % of
patients had not received a medical diagnosis, and thus
self-management of repiratory symptoms was common.
In spite of the limitations of the questionnaire-based
design, those findings highlight the problems of under-
diagnosis and under-treatment. The third article reviews
current literature on the increasingly common “obesel. This is an Open Access article distributed under the terms of the Creative
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and common co-morbidities; impact of overweight or
obesity on asthma control; growing evidence of distinct
endotypes of “obese asthma”; and treatment of patients
with co-existing obesity and asthma [8].
We conclude by inviting all of our esteemed colleagues
to submit their work to Asthma Research and Practice,
while also welcoming their suggestions to improve the
quality and reach of the journal.
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